Ayman Ibrahim

Global Head, Regulatory Affairs & Pharmacovigilance at mAbxience

Ayman Ibrahim is the Global Head of Regulatory Affairs & Pharmacovigilance at mAbxience, a biopharmaceutical company specializing in monoclonal antibodies and novel biopharmaceuticals. Prior to mAbxience, Ayman held leadership roles in regulatory affairs at Sandoz and Pharmascience. With a background in Cell and Molecular Biology, Ayman has a proven track record of successfully leading regulatory strategies and submissions for various markets worldwide. Ayman also holds an Executive MBA from Kellogg-WHU and has demonstrated expertise in global regulatory governance and market entry strategies.

Location

Madrid, Spain

Links

Previous companies


Org chart


Teams


Offices


mAbxience

mAbxience is a high growth international biotechnology company specialized in the research, development, manufacture and global commercialization of biopharmaceutical products to treat and prevent diseases across different therapeutic areas.


Industries

Headquarters

Madrid, Spain

Employees

201-500

Links